Emeryville, Calif., November 3, 2026 – Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Jennifer F. Tseng, MD, MPH, a nationally recognized surgical oncologist, to its Scientific Advisory Board. Dr.